[Diagnosis and treatment of psychogenic dizziness in patients with arterial hypertension].

Abstract

OBJECTIVE:

To analyze the prevalence, methods of diagnosis and treatment of psychogenic dizziness in patients with arterial hypertension and evaluate the efficacy of treatment with noophen and betahistin.

MATERIAL AND METHODS:

Fifty-eight patients were studied. Patients of the main group received noophen and patients of the comparison group were treated with betahistin. Treatment efficacy was assessed on days 1 and 60 by the scores on VAS, HARS, MFI-20 scales.

RESULTS AND CONCLUSION:

The prevalence of psychogenic dizziness in patients with arterial hypertension was 47%. Noophen in dose 500 mg/day significantly (p<0.001) reduced the severity of dizziness, anxiety, asthenia, and headache compared to baseline and to the efficacy of betahistin as well. The drug showed good tolerability.

• Authors: S N Duma, L V Shcherbakova
• Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 116 Issue 2 Pg. 62-66 ( 2016) ISSN: 1997-7298 [Print] Russia (Federation)
• PMID: 27029450 (Publication Type: Comparative Study, Controlled Clinical Trial, Journal Article)

Chemical References

• gamma-Aminobutyric Acid
• 4-amino-3-phenylbutyric acid
• Betahistine

Topics

• Aged
• Anxiety (drug therapy, psychology)
• Asthenia (drug therapy, psychology)
• Betahistine (therapeutic use)
• Dizziness (diagnosis, drug therapy, etiology)
• Female
• Humans
• Hypertension (complications, psychology)
• Male
• Treatment Outcome
• gamma-Aminobutyric Acid (analogs & derivatives, therapeutic use)